These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4926265)

  • 1. Passive serologic transfer of allograft immunity in immunologically suppressed mice. II. Effect of graft exposure to immune serum in primary hosts.
    Kinne DW; Simmons RL
    J Immunol; 1971 Mar; 106(3):629-34. PubMed ID: 4926265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of the immune reaction following skin allograft by antithymocyte serum therapy of the donors].
    Petrányi G; Szegedi G; Fekete B
    Orv Hetil; 1971 Aug; 112(31):1852-5. PubMed ID: 4941976
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive serologic transfer of immunity to skin grafts in allogeneic and isogeneic mice.
    Kinne DW; Simmons RL
    Rev Surg; 1971; 28(1):68. PubMed ID: 4925865
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of phytohemagglutinin on skin allograft survival in mice.
    Stefani SS; Moore CD
    J Immunol; 1970 Apr; 104(4):780-4. PubMed ID: 4910806
    [No Abstract]   [Full Text] [Related]  

  • 5. Passive serologic transfer of allograft immunity in immunologically suppressed mice. I. Immunosuppression by heterologous anti-lymphocyte serum.
    Kinne DW; Simmons RL
    J Immunol; 1967 Feb; 98(2):251-5. PubMed ID: 5335575
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of skin graft enhancement in the mouse.
    McKenzie IF; Koene R; Winn HJ
    Transplant Proc; 1971 Mar; 3(1):711-3. PubMed ID: 4106335
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological enhancement.
    Russell PS
    Transplant Proc; 1971 Mar; 3(1):960-6. PubMed ID: 4941150
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of action of antilymphocyte serum: effect on H-2 antibody formation, induction of allograft immunity, and tolerance to H-2 skin grafts.
    Franco DJ; Monaco AP
    Surg Forum; 1968; 19():175-7. PubMed ID: 4887902
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergism between cortisol and antilymphocyte serum. I. Observations in murine allograft systems.
    Gunn A; Lance EM; Medawar PB; Nehlsen SL
    Ciba Found Study Group; 1970; 36():66-72. PubMed ID: 4399436
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of skin allograft rejection by antilymphocytic serum pretreatment of the donor. Immunological preparation of the graft.
    Petrányi G; Szegedi G; Fekete B
    Acta Med Acad Sci Hung; 1971; 28(2):155-8. PubMed ID: 4948114
    [No Abstract]   [Full Text] [Related]  

  • 13. Allograft immunity produced with skin isografts from immunologically tolerant mice.
    Steinmuller D
    Transplant Proc; 1969 Mar; 1(1):593-6. PubMed ID: 4944275
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective action of homologous serum component on graft rejection.
    Hasek M; Karakoz I; Skamene E; Chutna J; Nouza K; Bubenik J; Nemec M; Sovova V
    Transplant Proc; 1969 Mar; 1(1):527-9. PubMed ID: 4944266
    [No Abstract]   [Full Text] [Related]  

  • 15. The macrophage in allograft immunity. II. Passive transfer with immune macrophages.
    Pearsall NN; Weiser RS
    J Reticuloendothel Soc; 1968 Apr; 5(2):121-33. PubMed ID: 4870365
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes.
    Mauel J; Rudolf H; Chapuis B; Brunner KT
    Immunology; 1970 Apr; 18(4):517-35. PubMed ID: 5421033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged rhesus skin allograft survival produced by antihuman thymocyte serum.
    Darrow CC; LaFontaine GS; Smith JJ; Martin DP; Sell KW; Kayhoe DE
    Transplant Proc; 1971 Mar; 3(1):730-2. PubMed ID: 4999466
    [No Abstract]   [Full Text] [Related]  

  • 18. Passive enhancement of skin heterografts.
    Jeekel J; Westbroek DL
    Transplant Proc; 1971 Mar; 3(1):714-6. PubMed ID: 4937964
    [No Abstract]   [Full Text] [Related]  

  • 19. Strength of H-2 and non-H-2 antigens as compared in ALS-suppressed recipients.
    Hilgert I; Nouza K
    Folia Biol (Praha); 1970; 16(6):369-73. PubMed ID: 4394676
    [No Abstract]   [Full Text] [Related]  

  • 20. [The feasibility of prolonging the visability of allotransplants by using antilymphocytic and antithrombocytic sera].
    Khundanov LI; Verbitskiĭ MSh; Artsimovich NG; Kipervasser EM; Lagutina NIa
    Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):42-50. PubMed ID: 4558981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.